These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 11253615)

  • 1. Peripheral link model as an alternative for pharmacokinetic-pharmacodynamic modeling of drugs having a very short elimination half-life.
    Laurin J; Donati F; Nekka F; Varin F
    J Pharmacokinet Pharmacodyn; 2001 Feb; 28(1):7-25. PubMed ID: 11253615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An interstitial compartment is necessary to link the pharmacokinetics and pharmacodynamics of mivacurium.
    Schiere S; Proost JH; Roggeveld J; Wierda M
    Eur J Anaesthesiol; 2004 Nov; 21(11):882-91. PubMed ID: 15717705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assuming peripheral elimination: its impact on the estimation of pharmacokinetic parameters of muscle relaxants.
    Laurin J; Nekka F; Donati F; Varin F
    J Pharmacokinet Biopharm; 1999 Oct; 27(5):491-512. PubMed ID: 10948695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamics of the benzylisoquinolinium muscle relaxants.
    Hull CJ
    Acta Anaesthesiol Scand Suppl; 1995; 106():13-7. PubMed ID: 8533537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on newer neuromuscular blocking drugs.
    Holm H; Ostergaard D
    Ann Acad Med Singap; 1994 Nov; 23(6 Suppl):108-13. PubMed ID: 7710219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacokinetics of the newer neuromuscular blocking drugs.
    Atherton DP; Hunter JM
    Clin Pharmacokinet; 1999 Mar; 36(3):169-89. PubMed ID: 10223167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mivacurium chloride--a comparative profile.
    Diffenbach C; Buzello W; Mellinghoff H
    Acta Anaesthesiol Scand Suppl; 1995; 106():23-5. PubMed ID: 8533540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of drug-induced low plasma cholinesterase activity on the pharmacokinetics and pharmacodynamics of mivacurium.
    Ostergaard D; Rasmussen SN; Viby-Mogensen J; Pedersen NA; Boysen R
    Anesthesiology; 2000 Jun; 92(6):1581-7. PubMed ID: 10839906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between suxamethonium and mivacurium or atracurium.
    Kim KS; Na DJ; Chon SU
    Br J Anaesth; 1996 Nov; 77(5):612-6. PubMed ID: 8957977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical and basic pharmacology of mivacurium: a short-acting nondepolarizing benzylisoquinolinium diester neuromuscular blocking drug.
    Savarese JJ; Lien CA; Belmont MR; Rubin L
    Acta Anaesthesiol Scand Suppl; 1995; 106():18-22. PubMed ID: 8533538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic-pharmacodynamic modeling of atracurium in intensive care patients.
    Farenc C; Lefrant JY; Audran M; Bressolle F
    J Clin Pharmacol; 2001 Jan; 41(1):44-50. PubMed ID: 11144993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentration-effect relationship of cisatracurium at three different dose levels in the anesthetized patient.
    Bergeron L; Bevan DR; Berrill A; Kahwaji R; Varin F
    Anesthesiology; 2001 Aug; 95(2):314-23. PubMed ID: 11506100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the neuromuscular blocking effects of atracurium, mivacurium, and vecuronium on the adductor pollicis and the orbicularis oculi muscle in humans.
    Rimaniol JM; Dhonneur G; Sperry L; Duvaldestin P
    Anesth Analg; 1996 Oct; 83(4):808-13. PubMed ID: 8831326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic-pharmacodynamic modeling of mivacurium in rats.
    Trocóniz IF; Garrido MJ; García E; Suárez E; Calvo R
    J Pharm Sci; 1997 Feb; 86(2):252-6. PubMed ID: 9040105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromuscular interaction between cisatracurium and mivacurium, atracurium, vecuronium or rocuronium administered in combination.
    Kim KS; Chun YS; Chon SU; Suh JK
    Anaesthesia; 1998 Sep; 53(9):872-8. PubMed ID: 9849281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newer neuromuscular blocking agents: how do they compare with established agents?
    Sparr HJ; Beaufort TM; Fuchs-Buder T
    Drugs; 2001; 61(7):919-42. PubMed ID: 11434449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The future of the benzylisoquinolinium relaxants.
    Savarese JJ; Wastila WB
    Acta Anaesthesiol Scand Suppl; 1995; 106():91-3. PubMed ID: 8533554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacodynamics of mivacurium preceded by atracurium or cisatracurium in children.
    Jalkanen L; Rautoma P; Taivainen T; Meretoja OA
    Anesth Analg; 1998 Jan; 86(1):62-5. PubMed ID: 9428852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discrepancy of recovery times related to potency between atracurium and mivacurium simultaneously administered in isolated forearms.
    Kim SY; Hwang KH; Ok SY; Kim SI; Kim SC; Park W
    Anaesthesia; 1995 Jun; 50(6):507-9. PubMed ID: 7618663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between mivacurium and atracurium.
    Naguib M; Abdulatif M; al-Ghamdi A; Selim M; Seraj M; el-Sanbary M; Magboul MA
    Br J Anaesth; 1994 Oct; 73(4):484-9. PubMed ID: 7999489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.